作者:
Harvey,R. [1]
;
Hamill,M. [2]
;
Robertson,J.S. [3]
;
Minor,P.D. [4]
;
Vodeiko,G.M. [5]
;
Weir,J.P. ;
Takahashi,H. ;
Harada,Y. ;
Itamura,S. ;
Bamford,P. ;
DallaPozza,T. ;
Engelhardt,O.G.
作者单位:
Therapeutic Goods Administration, Po Box 100, Woden ACT 2606, Australia
[1]
Division of Virology, National Institute for Biological Standards and Control, Health Protection
[2]
Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug
[3]
Center for Influenza Virus Research, National Institute of Infectious Diseases, Gakuen 4-7-1
[4]
National Institute for Biological Standards and Control, Health Protection Agency, Blanche Lane
[5]
发布时间
2013-11-20